Reason: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.
Distributed: Nationwide within the U.S.A.Reason: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.
Distributed: Nationwide within the U.S.A.Reason: Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Distributed: USA NationwideReason: Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.
Distributed: Nationwide in the USAReason: Failed Tablet/Capsule Specification : Capsule breakage
Distributed: USA NationwideReason: Lack of Assurance of Sterility
Distributed: Nationwide in the USAReason: Lack of Assurance of Sterility
Distributed: Nationwide in the USAReason: Lack of Assurance of Sterility
Distributed: Nationwide in the USAReason: Lack of Assurance of Sterility
Distributed: Nationwide in the USAReason: Lack of Assurance of Sterility
Distributed: Nationwide in the USA